"
Team:Columbia-Cooper-NYC/Safety
From 2012.igem.org
(Difference between revisions)
MChowdhury (Talk | contribs) (→Safety) |
MChowdhury (Talk | contribs) (→Safety) |
||
| Line 55: | Line 55: | ||
<h3>How could other teams learn from your experience?</h3> | <h3>How could other teams learn from your experience?</h3> | ||
| - | |||
| - | |||
| + | <h2>Is there a local biosafety group, committee, or review board at your institution?</h2> | ||
| + | <h3>If yes, what does your local biosafety group think about your project?</h3> | ||
| - | + | <h3>If no, which specific biosafety rules or guidelines do you have to consider in your | |
| - | + | country?</h3> | |
| - | If no, which specific biosafety rules or guidelines do you have to consider in your country? | + | |
<p>Genspace has an Advisory Board consisting of experts in biosafety, biosecurity, and genetic engineering who hold positions in academia, industry and government. They serve as our Institutional Biosafety Committee. The portions of the project to be carried out at Genspace are strictly BioBrick construction and the construction of plasmids containing metal-binding peptides and other non-pathogenic sequences. This is within the project parameters recommended by our Advisory Board.</p> | <p>Genspace has an Advisory Board consisting of experts in biosafety, biosecurity, and genetic engineering who hold positions in academia, industry and government. They serve as our Institutional Biosafety Committee. The portions of the project to be carried out at Genspace are strictly BioBrick construction and the construction of plasmids containing metal-binding peptides and other non-pathogenic sequences. This is within the project parameters recommended by our Advisory Board.</p> | ||
| Line 72: | Line 71: | ||
| - | Do you have any other ideas how to deal with safety issues that could be useful for future iGEM competitions? How could parts, devices and systems be made even safer through biosafety engineering? | + | <h2>Do you have any other ideas how to deal with safety issues that could be useful for future iGEM competitions? How could parts, devices and systems be made even safer through biosafety engineering?</h2> |
Revision as of 19:42, 31 May 2012
This is a template page. READ THESE INSTRUCTIONS.
You are provided with this team page template with which to start the iGEM season. You may choose to personalize it to fit your team but keep the same "look." Or you may choose to take your team wiki to a different level and design your own wiki. You can find some examples HERE.
You MUST have all of the pages listed in the menu below with the names specified. PLEASE keep all of your pages within your teams namespace.
| Home | Team | Official Team Profile | Project | Parts Submitted to the Registry | Modeling | Notebook | Safety | Attributions |
|---|
Safety
<body>
Would any of your project ideas raise safety issues in terms of:
researcher safety?
public safety?
environmental safety?
Do any of the new BioBrick parts (or devices) that you made this year raise any safety issues? If yes,
did you document these issues in the Registry?
how did you manage to handle the safety issue?
How could other teams learn from your experience?
Is there a local biosafety group, committee, or review board at your institution?
If yes, what does your local biosafety group think about your project?
If no, which specific biosafety rules or guidelines do you have to consider in your country?
Genspace has an Advisory Board consisting of experts in biosafety, biosecurity, and genetic engineering who hold positions in academia, industry and government. They serve as our Institutional Biosafety Committee. The portions of the project to be carried out at Genspace are strictly BioBrick construction and the construction of plasmids containing metal-binding peptides and other non-pathogenic sequences. This is within the project parameters recommended by our Advisory Board.
<a href="http://genspace.org/page/Advisory%20Board">Advisory Board Members</a>
Cooper Union does not have an Institutional Biosafety Committee, but the project has been reviewed by David Wootton, Ph.D., Director of The Maurice Kanbar Center for Biomedical Engineering and is being supervised by Jody Grapes, Campus-Wide Safety Officer for Cooper Union.
